Medical Detox Needs Rise as Sedative Taints Fentanyl Supply

People who use fentanyl today may be detoxing from more than one drug at once. A new study of patient experiences with medetomidine shows why complicated withdrawal belongs in medical detox.

Medetomidine is a powerful veterinary sedative that increasingly appears in the fentanyl supply. Researchers interviewed 16 hospitalized adults with opioid use disorder who had confirmed medetomidine exposure.

Four themes emerged from their accounts. They described having no control over what was in the drug supply. They also described the drug’s effects and severe withdrawal as well as the difficulty of getting treatment for a contaminant that most people had never heard of.

Medetomidine Is a Powerful Veterinary Sedative

Medetomidine belongs to a class of sedatives called alpha 2 agonists. Veterinarians use it as a sedative but the drug is not approved for human use. It is roughly 200 to 300 times more potent than xylazine.

The CDC has reported cases where medetomidine slowed heart rates to as low as 32 beats per minute. The drug can also cause low blood pressure and profound sedation that may last for an extended period.

Health officials have linked medetomidine to overdose clusters in Chicago and Philadelphia as well as Pittsburgh and Maryland. The drug usually appears alongside fentanyl.

Naloxone does not reverse medetomidine sedation. It remains essential, because it can reverse the opioid effects of fentanyl. Someone can respond to naloxone and still remain dangerously sedated from medetomidine.

Medetomidine Withdrawal Can Become Severe

Medetomidine withdrawal is a separate medical event from opioid withdrawal. The CDC describes a severe syndrome that can begin within hours after the last use and peak 18 to 36 hours later.

Symptoms can include a rapid heart rate, severely elevated blood pressure and sometimes changes in alertness and tremors as well as chest pain and severe nausea or vomiting. Some cases have required emergency care or intensive care.

Philadelphia’s health department has managed medetomidine clusters firsthand. The department recommends treating opioid withdrawal first with buprenorphine or methadone. Clinicians can also add clonidine early when patients are medically stable.

That combination of medication and monitoring requires clinical judgment. Medical detox programs provide that level of care.

Patient Stories Show the Risk

Statistics explain what medetomidine can do but patient interviews show what withdrawal can feel like.

People in the study described not knowing what they were taking. They also described withdrawal that felt unlike anything they had experienced before and hospital care that became necessary because they had no control over the drug supply.

That matters if you are considering detox today. Street fentanyl can contain substances that you cannot identify by appearance or experience.

Fentanyl test strips can detect fentanyl and some fentanyl analogs but they don’t detect veterinary sedatives such as medetomidine. No test strips currently detect medetomidine.

Find Medical Detox

If you or someone you love uses fentanyl or other opioids do not attempt detox alone. Fentanyl mixed with sedatives can produce withdrawal that changes quickly and requires medical monitoring.

Medical detox centers provide around the clock monitoring and medications for opioid withdrawal. Staff can also respond if blood pressure or heart rate becomes unstable.

Medications for opioid use disorder, such as methadone or buprenorphine, can reduce overdose risk and support long term recovery.

Detox.com’s directory lists detox centers and medical detox programs across the nation. Call 800-996-6135Sponsored to find a program equipped to handle the current drug supply rather than the one people faced a year ago.